Preparation and initial characterization of biodegradable particles containing gadolinium-DTPA contrast agent for enhanced MRI.
about
Hybrid nanoparticles for detection and treatment of cancerNovel delivery strategies for glioblastomaNovel polymeric nanoparticles for intracellular delivery of peptide Cargos: antitumor efficacy of the BCL-2 conversion peptide NuBCP-9Preparation and characterization of gadolinium-loaded PLGA particles surface modified with RGDS for the detection of thrombusPoly(lactic-co-glycolic) acid as a carrier for imaging contrast agents.Multimodality imaging probes: design and challenges.Plasma, tumor and tissue pharmacokinetics of Docetaxel delivered via nanoparticles of different sizes and shapes in mice bearing SKOV-3 human ovarian carcinoma xenograft.Nanoparticles as magnetic resonance imaging contrast agents for vascular and cardiac diseases.Pharmacokinetics of silybin nanoparticles in mice bearing SKOV-3 human ovarian carcinoma xenocraftDevelopment of a robust pH-sensitive polyelectrolyte ionomer complex for anticancer nanocarriers.Target binding improves relaxivity in aptamer-gadolinium conjugates.Hydrogels incorporating GdDOTA: towards highly efficient dual T1/T2 MRI contrast agents.Synthesis route and three different core-shell impacts on magnetic characterization of gadolinium oxide-based nanoparticles as new contrast agents for molecular magnetic resonance imaging.Targeted Therapeutic Nanoparticles: An Immense Promise to Fight against Cancer.Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agentConvenient grafting through approach for the preparation of stealth polymeric blood pool magnetic resonance imaging contrast agentsPreparation and Evaluation of Multiple Nanoemulsions Containing Gadolinium (III) Chelate as a Potential Magnetic Resonance Imaging (MRI) Contrast AgentPAMAM Dendrimers as Potential Carriers of Gadolinium Complexes of Iminodiacetic Acid Derivatives for Magnetic Resonance Imaging
P2860
Q26849404-AB990B17-5338-499A-B687-10FD1FCDC514Q27006099-DA203D9A-6863-46C7-9AA6-C63FE4BBF8ACQ28389837-BE594F8C-34BB-4E9F-9591-2B72E5CC25DBQ30448359-7BD4BB67-7701-4F61-8474-29B687657F2FQ30481085-1D89A3D5-BD92-4957-B994-BBB5A0D9E1F5Q33884695-713EF03A-ED79-48F1-825E-BD4C553C46EEQ34316088-73674ED6-579F-4718-8569-77B8C82229F8Q35667247-B8C387B0-C05B-4F49-9789-5A80E207F073Q36411512-FC22A721-C666-401F-A9AB-DC0B978CEAE9Q36623682-1BBB094C-AD06-49B8-A5D0-13CCBAE9034FQ38322510-6B83A969-9154-4131-B8FD-826E5C804B1BQ39302040-030C9D09-3F39-42E3-AF08-83D13604EE11Q41127223-5721820D-512F-4BAF-AD04-CF4BF0B45EAFQ49787181-E59D1ACE-2CE5-461F-8BB3-CA57CCF6CB8AQ57184960-657D456A-13C4-45F4-BDE2-D5668C8E40DFQ57344842-D855CF7B-AFEF-442D-9781-FC33089A35CDQ58479805-294E3278-1832-4652-8348-361CFA02EA49Q59113418-C58533B3-D476-4C46-A8CE-FB58577DA39E
P2860
Preparation and initial characterization of biodegradable particles containing gadolinium-DTPA contrast agent for enhanced MRI.
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Preparation and initial charac ...... ntrast agent for enhanced MRI.
@ast
Preparation and initial charac ...... ntrast agent for enhanced MRI.
@en
type
label
Preparation and initial charac ...... ntrast agent for enhanced MRI.
@ast
Preparation and initial charac ...... ntrast agent for enhanced MRI.
@en
prefLabel
Preparation and initial charac ...... ntrast agent for enhanced MRI.
@ast
Preparation and initial charac ...... ntrast agent for enhanced MRI.
@en
P2093
P2860
P356
P1476
Preparation and initial charac ...... ontrast agent for enhanced MRI
@en
P2093
Lisa Brannon-Peppas
P2860
P304
17232-17237
P356
10.1073/PNAS.0710205105
P407
P577
2008-09-16T00:00:00Z